D-Nome's focus is to build rapid point-of-care diagnostics for human infectious diseases and other applications using genomics and synthetic biologyfrom Tech-Economic Times https://ift.tt/O9jHtxR
Saturday, January 21, 2023
Subscribe to:
Post Comments (Atom)
-
The German cabinet will hold a secret session on Wednesday to discuss safeguard measures regarding the possible participation of China's...
-
The Devas shareholders are enforcing an International Chamber of Commerce arbitral award of $1.2 billion to Devas, owed by ISRO commercial a...
No comments:
Post a Comment